Download pdf - MOHRUS paps XR 120 240 210730 - hisamitsu-pharm.jp

Transcript

Page 1: MOHRUS paps XR 120 240 210730 - hisamitsu-pharm.jp

Recommended

Hisamitsu Pharmaceutical Co., Inc. Q1 FY02/2020 Results...actual actual actual actual actual forecast target - April, 2017: Establishment of th The 6 Mid-term management policy Promoting

Hisamitsu Pharmaceutical Co., Inc. Q1 FY02/2020 Results...actual actual actual actual actual forecast target - April, 2017: Establishment of th The 6 Mid-term management policy Promoting Documents

CSR and the Hisamitsu Springs’ KAYASHIMA, Akira · 2020. 1. 24. · KAYASHIMA, Akira General Manager, Hisamitsu Springs I believe that Hisamitsu Springs is an important asset for

CSR and the Hisamitsu Springs’ KAYASHIMA, Akira · 2020. 1. 24. · KAYASHIMA, Akira General Manager, Hisamitsu Springs I believe that Hisamitsu Springs is an important asset for Documents

社会とのかかわり - Hisamitsu · ギリシャ悲劇まで幅広い作品を世に送り出してきました。その活躍は日本国内だけではなく海外でも広く注

社会とのかかわり - Hisamitsu · ギリシャ悲劇まで幅広い作品を世に送り出してきました。その活躍は日本国内だけではなく海外でも広く注 Documents

ポスターについて - kanazawa-univ-pharm.jpkanazawa-univ-pharm.jp/.../rep/files/26anemia_H26_3-3.pdf巨赤芽球性貧血今回は最も多い鉄欠乏性貧血について説明します

ポスターについて - kanazawa-univ-pharm.jpkanazawa-univ-pharm.jp/.../rep/files/26anemia_H26_3-3.pdf巨赤芽球性貧血今回は最も多い鉄欠乏性貧血について説明します Documents

NDA 210730 NDA APPROVAL...2017/11/02 · NDA 210730 Page 4 3902-4 Conduct a randomized, controlled trial evaluating the safety, tolerability, and efficacy profiles of OLINVYK in pediatric

NDA 210730 NDA APPROVAL...2017/11/02 · NDA 210730 Page 4 3902-4 Conduct a randomized, controlled trial evaluating the safety, tolerability, and efficacy profiles of OLINVYK in pediatric Documents

骨粗鬆症 - kanazawa-univ-pharm.jpkanazawa-univ-pharm.jp/.../rep/files/29_3_2_osteoporosis.pdf出典山本逸雄ほか, Osteoporosis Jpn., 7（1）, 10, 1999 ① ビスホスホネート製剤

骨粗鬆症 - kanazawa-univ-pharm.jpkanazawa-univ-pharm.jp/.../rep/files/29_3_2_osteoporosis.pdf出典山本逸雄ほか, Osteoporosis Jpn., 7（1）, 10, 1999 ① ビスホスホネート製剤 Documents

Hisamitsu Pharmaceutical co.,inc. · Active involvement of management Resource conservation Energy conservation • Waste reduction • Work style reform Respect for human rights

Hisamitsu Pharmaceutical co.,inc. · Active involvement of management Resource conservation Energy conservation • Waste reduction • Work style reform Respect for human rights Documents

KazuhideNakatomi, President & COO · Bringing Patch Culture to the World 3 Hisamitsu Pharmaceutical's Vision Capturing a 1% share of the global market of "Pharmaceuticals" Capturing

KazuhideNakatomi, President & COO · Bringing Patch Culture to the World 3 Hisamitsu Pharmaceutical's Vision Capturing a 1% share of the global market of "Pharmaceuticals" Capturing Documents

Hisamitsu Pharmaceutical Co., Inc. · For OTC pharma-ceuticals, we engaged in activities to create new customers ... by engaging in the ethical pharmaceuticals business with a focus

Hisamitsu Pharmaceutical Co., Inc. · For OTC pharma-ceuticals, we engaged in activities to create new customers ... by engaging in the ethical pharmaceuticals business with a focus Documents

X-Ray Imaging Spectrometer (XIS) on Board Suzaku · Shunji KITAMOTO,9 Masahiro TSUJIMOTO,9 Takayoshi KOHMURA,10 Yohko TSUBOI,11 and Hisamitsu AWAKI12 1Department of Physics, Graduate

X-Ray Imaging Spectrometer (XIS) on Board Suzaku · Shunji KITAMOTO,9 Masahiro TSUJIMOTO,9 Takayoshi KOHMURA,10 Yohko TSUBOI,11 and Hisamitsu AWAKI12 1Department of Physics, Graduate Documents

Timor-Leste Project for the Development of a Water … Timor-Leste Project for the Development of a Water Supply Service in Same and Ainaro External Evaluator: Hisamitsu Shimoyama,

Timor-Leste Project for the Development of a Water … Timor-Leste Project for the Development of a Water Supply Service in Same and Ainaro External Evaluator: Hisamitsu Shimoyama, Documents

9 2016 - Hisamitsu Pharmaceutical · all those affected by the 2016 Kumamoto Earthquake and hope for a rapid recovery of the affected areas. We hereby report the overview of operations

9 2016 - Hisamitsu Pharmaceutical · all those affected by the 2016 Kumamoto Earthquake and hope for a rapid recovery of the affected areas. We hereby report the overview of operations Documents

Hisamitsu Pharmaceutical Co., Inc. PHARMACEUTICAL CO., INC 2 FINANCIAL REPORT 2013 To Our Stakeholders The market environment for the ethical pharmaceutical industry in Japan during

Hisamitsu Pharmaceutical Co., Inc. PHARMACEUTICAL CO., INC 2 FINANCIAL REPORT 2013 To Our Stakeholders The market environment for the ethical pharmaceutical industry in Japan during Documents

IPEC-Americas General Update€¦ · Noven Pharmaceuticals (subsidiary of Hisamitsu), Mylan, Teva, Novartis, ... • Financial loss of $34,000 ... innovative drug formulations. A

IPEC-Americas General Update€¦ · Noven Pharmaceuticals (subsidiary of Hisamitsu), Mylan, Teva, Novartis, ... • Financial loss of $34,000 ... innovative drug formulations. A Documents

Hisamitsu Pharmaceutical Co., Inc. Q1 FY02/2021 Results ... · Promoting Patch Treatment Culture Worldwide Agenda Q1 FY02/2021 Results 1．Response and impact of COVID-19 2．Looking

Hisamitsu Pharmaceutical Co., Inc. Q1 FY02/2021 Results ... · Promoting Patch Treatment Culture Worldwide Agenda Q1 FY02/2021 Results 1．Response and impact of COVID-19 2．Looking Documents

PCO3 PUREAIR™ AIR PURIFICATION SYSTEM INDOOR ......HEALTHY CLIMATE® PureAir Air Purification System Bulletin No. 210730 April 2015 PRODUCT SPECIFICATIONS Supersedes February 2015

PCO3 PUREAIR™ AIR PURIFICATION SYSTEM INDOOR ......HEALTHY CLIMATE® PureAir Air Purification System Bulletin No. 210730 April 2015 PRODUCT SPECIFICATIONS Supersedes February 2015 Documents

料金表506506.ntt.com/request/pdf/0033sm_pricelist.pdfTitle 料金表.indd Author hisamitsu Created Date 8/7/2009 4:37:31 PM

料金表506506.ntt.com/request/pdf/0033sm_pricelist.pdfTitle 料金表.indd Author hisamitsu Created Date 8/7/2009 4:37:31 PM Documents

010 0707301373007.indd 2 2018/08/29 14:17:39 · HISAMITSU PHARMACEUTICAL CO., INC. 1 FINANCIAL REPORT 2018 Consolidated Financial Highlights (Millions of yen) (Thousands of U.S. dollars)

010 0707301373007.indd 2 2018/08/29 14:17:39 · HISAMITSU PHARMACEUTICAL CO., INC. 1 FINANCIAL REPORT 2018 Consolidated Financial Highlights (Millions of yen) (Thousands of U.S. dollars) Documents